August 26, 2025 – For the first time in Israel, Rambam Health Care Campus (Rambam) is testing a revolutionary gene-editing treatment that could halt a deadly form of heart failure. The same technology may soon target another global killer: high cholesterol. In collaboration with Intellia Therapeutics, a U.S. biotech company, Rambam is conducting the first…
June 10, 2024 – A recent study conducted at the Heart Failure Unit at Rambam Health Care Campus (Rambam) in Haifa, Israel, examined three primary treatments for persistent fluid buildup in heart failure patients. The study evaluated the safety of each approach and pinpointed the most effective treatment, positioning it to improve patient care worldwide. Heart…
Today, more than ever, artificial heart implantation is becoming an excellent, accessible solution for people suffering from extreme heart failure, the epidemic of the Western world. Patients no longer have to wait years for a donor heart. The third generation of artificial hearts is here, and accessibility is growing. Amna Hijazi, a 69-year-old resident of…
